乳腺癌内乳淋巴结放疗的研究进展

Advances in internal mammary lymph node radiotherapy for breast cancer

乳腺癌是目前女性患者中最为高发的恶性肿瘤,全世界每年患乳腺癌的女性患者超100万。乳腺癌术后放射治疗是早期乳腺癌患者的重要治疗方案,术后放疗明显降低乳腺癌患者的死亡率和复发率已被广泛证实。乳腺癌根治术后行内乳淋巴结照射可提高早期乳腺癌患者的生存目前尚有争议。文章主要回顾乳腺癌内乳淋巴结放疗的技术、剂量选择、生存及不良反应相关的研究,对内乳淋巴结放疗研究进展进行综述。

Breast cancer is currently among the most frequently occurring malignant tumors in female patients,with more than one million female patients suffering from breast cancer worldwide each year.Postoperative radiotherapy for breast cancer treatment is an important treatment option for patients with early breast cancer,which could significantly reduce the mortality and recurrence rate of breast cancer patients.Intramammary lymph node irradiation after radical mastectomy could improve the survival of patients with early breast cancer is currently be of controversy.This study mainly reviews the research progress of internal mammary lymph node radiotherapy,including the techniques,dose selection,survival,and adverse reaction-related reports.